Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells

Journal of Neuroimmunology

Volumn 85, Issue 1, 1998, Pages 87-95

  Badovinac, Vladimir ^a   Mostarica Stojković, Marija ^b   Dinarello, Charles A ^c   Stošić Grujičić, Stanislava ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Encephalitogenic lymphocytes; Experimental allergic encephalomyelitis; Interleukin 1 receptor antagonist; Rat

Indexed keywords

ENCEPHALITOGENIC PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032077870     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00020-4     Document Type: Article

References (31)

1. Aiura K., Gelfand J.A., Burke J.E., Thompson R.C., Dinarello C.A. Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1β in rabbits. Infect. Immun. 61:1993;3342-3350.
2. Antin J.H., Weinstein H.J., Guinan E.C., McCarthy P., Bierer B.E., Gilliland D.G., Parsons S.K., Ballen K.K., Rimm I.J., Falzarano G., Bloedow D.C., Abate L., Lebsack M., Burakoff S.J., Ferrara J.L.M. Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease. Blood. 84:1994;1342-1348.
3. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Jr. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
4. Bauer J., Berkenbosh F., Van Dam A.-M., Dijkstra C.D. Demonstration of interleukin-1beta in Lewis rat brain during experimental allergic encephalomyelitis by immunocytochemistry at the light and ultrastructural level. J. Neuroimmunol. 48:1993;13-32.
5. Canella B., Raine C.S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37:1995;424-435.
6. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood. 87:1996;2095-2147.
7. Day M.J., Mason D.W. Loss of encephalitogenicity of a myelin basic protein-specific T cell line is associated with a phenotypic change but not with alteration in production of interleukin-2, γ-interferon or tumor necrosis factor. J. Neuroimmunol. 30:1990;53-59.
8. Dayer-Matroz M.D., Duhamel D., Rufer N., Izui S., Carmichaels D., Wollheim C.B., Thompson R.C., Dayer J.-M. IL-1 receptor antagonist delays spontaneous autoimmune diabetes in BB rats. Eur. J. Clin. Invest. 22:1992;A50.
9. Esser R.E., Stimpson S.A., Cromartie W.J., Schwab J.H. Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. Arthritis Rheum. 28:1985;1402-1411.
10. Hayosh N.S., Swanborg R.H. Inhibition of adoptive transfer of autoimmune encephalomyelitis with a monoclonal antibody specific for interleukin 2 receptors. J. Immunol. 138:1987;3771-3775.
11. Hogg N., Berlin C. Structure and function of adhesion receptors in leukocyte trafficking. Immunol. Today. 16:1995;327-330.
12. Ikejima T., Ikusawa S., Ghezzi P., van den Meer J.W.M., Dinarello C.A. Interleukin-1 (IL-1) induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J. Infect. Dis. 162:1990;215-223.
13. Jacobs C.A., Baker P.E., Roux E.R., Picha K.S., Toivola B., Waugh S., Kennedy M.K. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J. Immunol. 146:1991;2983-2989.
14. Kaye J., Gillis S., Mizel S.B., Shevach E.M., Malek T.R., Dinarello C.A., Lachman L.B., Janeway C.A. Jr. Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J. Immunol. 133:1984;1339-1345.
15. Lub M., van Kooyk Y., Figdor C.G. Ins and outs of LFA-1. Immunol. Today. 16:1995;479-483.
16. Lukić, M.L., Stošić-Grujičić, S., Shahin, A. 1997. Effector mechanisms in low dose streptozotocin induced diabetes. Dev. Immunol., in press.
17. Mannie M.D., Dinarello C.A., Paterson P.Y. Interleukin 1 and myelin basic protein synergistically augment adoptive transfer activity of lymphocytes mediating experimental autoimmune encephalomyelitis in Lewis rats. J. Immunol. 138:1987;4229-4235.
18. Martin D., Near S.L. Protective effect of the interleukin-1 receptor antagonist (IL-1Ra) on experimental allergic encephalomyelitis in rats. J. Neuroimmunol. 61:1995;241-245.
19. Mostarica-Stojkovic,́, M., Radojković, M., Vukmanović, S., Ramić, Z., Vučković, S., Simić, M.M., Lukić, M.L. 1991. Elimination of CD8-positive T cells does not abrogate the resistance to experimental allergic encephalomyelitis in rats. In: Imhof, B.A., Berrih-Aknin, S., Ezine, S. (Eds.), Lymphatic Tissues and In Vivo Immune Responses. Marcel Dekker, New York, pp. 619-623.
20. Ohlsson K., Bjork P., Bergenfeldt M., Hageman R., Thompson R.C. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 348:1990;550-552.
21. Ovadia H., Paterson P.Y. Enhanced proliferation, survival and yield of cultured myelin basic protein (MBP)-reactive Lewis rat lymph node cells following dual activation with Concanavalin A and MBP. Cell. Immunol. 65:1981;380-385.
22. Panitch H.S. Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: comparison of in vitro activation by Concanavalin A and myelin basic protein. Cell. Immunol. 56:1980;163-181.
23. Petinelli C.B., McFarlin D.E. Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+2-T lymphocytes. J. Immunol. 127:1981;1420-1423.
24. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
25. Ruuls S.R., Van Der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
26. Schwab J.H., Anderle S.K., Brown R.R., Dalldorf F.G., Thompson R.C. Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect. Immun. 59:1991;4436-4442.
27. + (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 18:1988;495-502.
28. Sedgwick J., Brostoff S., Mason D. Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction: severe paralytic disease correlates with the presence of interleukin-2 receptor-positive cells infiltrating the central nervous system. J. Exp. Med. 165:1987;1058-1075.
29. Symons J.A., Bundick R.V., Suckling A.J., Rumsby M.G. Cerebrospinal fluid interleukin 1 activity during chronic relapsing experimental allergic encephalomyelitis. Clin. Exp. Immunol. 68:1987;648-654.
30. Trotter J., Sriram S., Rassenti L., Jen Chou C.-H., Fritz R.B., Steinman L. Characterization of T cell lines and clones from SJL/J and (Balb/c×SJL/J) F1 mice specific for myelin basic protein. J. Immunol. 134:1985;2322-2327.
31. Vukmanović S., Mostarica Stojković M., Lukić M.L. Experimental autoimmune encephalomyelitis in 'low' and 'high' interleukin 2 producer rats. Cell. Immunol. 121:1989;237-246.